Home/Filings/4/0001209191-14-049922
4//SEC Filing

EveryWare Global, Inc. 4

Accession 0001209191-14-049922

CIK 0001532543operating

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 4:05 PM ET

Size

27.7 KB

Accession

0001209191-14-049922

Insider Transaction Report

Form 4
Period: 2014-07-30
Collin Daniel
Director10% Owner
Transactions
  • Award

    Warrants to Purchase Common Stock

    2014-07-30+2,736,3552,736,355 total(indirect: By Monomoy Capital Partners, L.P.)
    Exercise: $0.01Exp: 2021-07-30Common Stock (2,736,355 underlying)
  • Award

    Warrants to Purchase Common Stock

    2014-07-30+14,16714,167 total(indirect: By Monomoy Executive Co-Investment Fund, L.P.)
    Exercise: $0.01Exp: 2021-07-30Common Stock (14,167 underlying)
  • Award

    Warrants to Purchase Common Stock

    2014-07-30+85,06785,067 total(indirect: By MCP Supplemental Fund, L.P.)
    Exercise: $0.01Exp: 2021-07-30Common Stock (85,067 underlying)
  • Award

    Series A Preferred Stock

    2014-07-30+13,071.35413,071.354 total(indirect: By Monomoy Capital Partners, L.P.)
  • Award

    Series A Preferred Stock

    2014-07-30+406.361406.361 total(indirect: By MCP Supplemental Fund, L.P)
  • Award

    Series A Preferred Stock

    2014-07-30+7,419.6177,419.617 total(indirect: By Monomoy Capital Partners II, L.P.)
  • Award

    Series A Preferred Stock

    2014-07-30+234.996234.996 total(indirect: By MCP Supplemental Fund III, L.P.)
  • Award

    Warrants to Purchase Common Stock

    2014-07-30+1,553,2211,553,221 total(indirect: By Monomoy Capital Partners II, L.P.)
    Exercise: $0.01Exp: 2021-07-30Common Stock (1,553,221 underlying)
  • Award

    Warrants to Purchase Common Stock

    2014-07-30+49,19449,194 total(indirect: By MCP Supplemental Fund II, L.P.)
    Exercise: $0.01Exp: 2021-07-30Common Stock (49,194 underlying)
  • Award

    Series A Preferred Stock

    2014-07-30+67.67267.672 total(indirect: By Monomoy Executive Co-Investment Fund, L.P.)
Footnotes (8)
  • [F1]An aggregate of 20,000 shares of Series A Preferred Stock were purchased for $1,000 per share, and an additional 1,200 shares of Series A Preferred Stock were issued as a fee in connection with the transaction.
  • [F2]These shares are held directly by Monomoy Capital Partners, L.P. ("MCP"). Monomoy General Partner, L.P. ("Monomoy GP") is the general partner of MCP, and Monomoy Ultimate GP, LLC ("Ultimate GP") is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP, except to the extent of his pecuinary interest therein.
  • [F3]These shares are held directly by MCP Supplemental Fund, L.P. ("MCP Supplemental Fund"). Monomoy GP is the general partner of MCP Supplemental Fund, and Ultimate GP is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP Supplemental Fund. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP Supplemental Fund, except to the extent of his pecuinary interest therein.
  • [F4]These shares are held directly by Monomoy Executive Co-Investment Fund, L.P. ("Co-Investment Fund"). Monomoy GP is the general partner of Co-Investment Fund, and Ultimate GP is the general partner of Monomoy GP. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by Co-Investment Fund. The reporting person expressly disclaims beneficial ownership of shares held directly by Co-Investment Fund, except to the extent of his pecuinary interest therein.
  • [F5]These shares are held directly by Monomoy Capital Partners II, L.P. ("MCP II"). Monomoy General Partner II, L.P. ("Monomoy GP II") is the general partner of MCP II, and Ultimate GP is the general partner of Monomoy GP II. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP II. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP II, except to the extent of his pecuinary interest therein.
  • [F6]These shares are held directly by MCP Supplemental Fund II, L.P. ("MCP Supplemental Fund II"). Monomoy GP II is the general partner of MCP Supplemental Fund II, and Ultimate GP is the general partner of Monomoy GP II. The reporting person is a managing member of Ultimate GP. As such, the reporting person may be deemed to have an indirect pecuniary interest in the shares held directly by MCP Supplemental Fund II. The reporting person expressly disclaims beneficial ownership of shares held directly by MCP Supplemental Fund II, except to the extent of his pecuinary interest therein.
  • [F7]Unless and until EveryWare Global, Inc. ("EveryWare") obtains any stockholder approval required by Nasdaq Listing Rule 5635 to permit full exercisability of the warrants, the number of shares of EveryWare common stock ("Common Stock") for which the warrants will be exercisable will be limited to the number of shares of Common Stock that, when taken together with all shares of Common Stock issued or issuable upon exercise of the warrants issued to lenders under the EveryWare's term loan, would be equal to 19.9% of the outstanding shares of the Common Stock as of the date of issuance of the warrants.
  • [F8]These warrants were issued together with the shares of Series A Preferred Stock reported in Table I.

Issuer

EveryWare Global, Inc.

CIK 0001532543

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001532543

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:05 PM ET
Size
27.7 KB